# Research on Early Diagnosis and Risk Stratification Biomarkers of Anti-Tumor Drug-Associated Interstitial Pneumonia Driven by Multi-Omics Integration

> **NCT07190703** · — · NOT_YET_RECRUITING · sponsor: **Fuzhou University Affiliated Provincial Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Anti-Tumor Drug-Associated Interstitial Pneumonia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07190703
- **Lead sponsor:** Fuzhou University Affiliated Provincial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07190703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07190703, "Research on Early Diagnosis and Risk Stratification Biomarkers of Anti-Tumor Drug-Associated Interstitial Pneumonia Driven by Multi-Omics Integration". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07190703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*